Do you want to know more about Parkinson's? PDF's materials provide information about symptoms, medications, resources & more.
Sign Up Now For PAN's Webcast and Hear From Experts About How the Food & Drug Administrationís Work Impacts the Parkinson's Community!
- Dec 12 2011
Join the Parkinson's Action Network (PAN) and viewers across the country for a live, educational webcast and learn why the Food and Drug Administration is important to the Parkinson's community! This informative webcast provides a unique opportunity to gain valuable insights into the FDA, the role it plays in therapy development, and possible areas for needed change and improvement.
When: Monday, December 12
3:00 PM – 4:30 PM EST
Where: Click here to register online to view the webcast and submit questions for discussion by our panelists. Can’t join us today? The webcast will be archived online for future viewing!
Amy Comstock Rick, J.D.,
CEO, Parkinson's Action Network
Marc Walton, M.D., Ph.D.
Associate Director for Translational Medicine in the Office of Translational Sciences at the Center for Drug Evaluation and Research, FDA
Michelle McMurry-Heath, M.D., Ph.D.
Associate Director for Science at the Center for Devices and Radiological Health, FDA
Cartier Esham, Ph.D.
Senior Director of Emerging Companies Health and Regulatory Affairs for the Biotechnology Industry Organization (BIO)
Patient-Representative to the Food and Drug Administration's Office of Special Health Issues and PDF Research Advocate
This program is made possible by a conference support grant awarded from and administered by the Telemedicine & Advanced Technology Research Center (TATRC) of the U.S. Army Medical Research & Materiel Command (USAMRMC), Award # W23RYX1067N603
With additional contributions from: EMD Serono
PAN is the voice of the Parkinson's community in Washington, DC. In 2011, PDF is supporting PAN with a grant of $200,000.
Source Date: Dec 12 2011